It was previously shown that CD44 expression can be regulated by IL‐4/STAT6 signaling.11 We therefore measured CD44 expression in the basal‐like prostate cancer cell lines PC3 and Du‐145 using flow cytometry after 20 passages of treatment with 5 ng/mL IL‐4. Here, STAT6 is linked to prostate carcinoma.